-
Published07/08/2025
-
Deadline08/09/2025
-
Opening of tenders08/09/2025
-
Awarded03/10/2025
-
Today15/05/2026
Utilities
- indicates text translated automatically in your browsing language
PALIVIZUMAB
It is used to prevent serious lower respiratory tract disease requiring hospitalisation caused by respiratory syncytial virus (RSV) in children at high risk of RSV disease. The medicine is given seasonally from October to April.
http://www.isepvo.sk
http://www.isepvo.sk
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.